QIAGEN IPA
Systems analysis of cancer cell lines for drug target discovery
291 views
This 90-minute event will show how our platform enables scientists:
• Select appropriate cancer cell lines for a variety of applications such as drug discovery, precision disease modeling, understanding gene function in cancer, immune-oncology research.
• Generate hypothesis and test it in-silico to improve translation of insights derived from cell line models to the drug target identification.
• How to prioritize drug targets and profile phenotypic/downstream effects of drug action.
• Integrated analyses of public 'omics data and drug response phenotypes using cell line model systems
Our system uses millions of curated literature findings in the QIAGEN/ IPA knowledge base and the OmicSoft digital warehouse. The presentation is intended for both those familiar with Ingenuity Pathway and newcomers interested in learning more.
Related videos
Discovery and Research
Discovery from public oncological data using QIAGEN Omicsoft OncoLand and QIAGEN Ingenuity...
In this 90-minute training, we will discuss how to discover and validate...
QIAGEN IPA
IPA Deep Dive: Generating Novel Discoveries in IPA - even when you don’t have data
Take a deeper dive into the discovery capabilities of QIAGEN IPA. In this...
QIAGEN IPA
Single Cell Analysis of the tumor microenvironmnet in High-grade Serous Ovarian Cancer (HGSOC)
Single-cell RNA sequencing (scRNA-seq) is an important technology that...
QIAGEN IPA
QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features
QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid...